Sustained release intranasal formulation and method of use there

Details Sustained release intranasal formulation and method of use there Sustained release intranasal formulation and method of use there

1985-01-28

1986-04-08

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

A61K 912, A61K 972, A61K 31135

Patent

active

045812250

ABSTRACT:
Administration of a catecholamine by a novel intranasal delivery system provides prolonged blood levels of the drug.

REFERENCES:
patent: 3039929 (1962-06-01), Stanko
patent: 3069319 (1962-12-01), Stearns et al.
patent: 3106511 (1963-10-01), Cuttler et al.
patent: 3155574 (1964-11-01), Silson et al.
patent: 3159535 (1964-12-01), Sesso et al.
patent: 3219533 (1965-11-01), Mullins
patent: 3282781 (1966-11-01), Macek et al.
patent: 3304230 (1967-02-01), Abramson et al.
patent: 3320125 (1967-05-01), Grim
patent: 3322625 (1967-05-01), Shimmin
patent: 3406237 (1968-10-01), Zeile et al.
patent: 3419658 (1968-12-01), Sanders
patent: 3482015 (1969-12-01), Bollinger et al.
patent: 3608065 (1971-09-01), Lover et al.
patent: 3671625 (1972-06-01), Altounyan
patent: 3987200 (1976-10-01), Tuttle et al.
patent: 4001391 (1977-01-01), Feinstone et al.
patent: 4016279 (1977-04-01), Bauer et al.
patent: 4175128 (1979-11-01), Taylor
patent: 4284648 (1981-08-01), Hussain et al.
patent: 4385048 (1983-05-01), Mygind et al.

Affiliated with

Also associated with

Rating

Sustained release intranasal formulation and method of use there does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release intranasal formulation and method of use there, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release intranasal formulation and method of use there will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2065204